Epstein-Barr virus
Epstein-Barr Virus-Positive Follicular Lymphoma with High PD-L1 Expression Demonstrates Promising Treatment Outcomes
Research conducted at Yantai Yuhuangding Hospital in Shandong, People's Republic of China, has shed new light on Epstein-Barr virus-positive follicular lymphoma, a rare and aggressive form of cancer. A case study published in Frontiers in Immunology presents a patient who was treated with R-CHOP chemotherapy combined with rituximab,